The National Comprehensive Cancer Network (NCCN) [20], American Society of Clinical Oncology (ASCO) [21] as well as others [22], recommend germline BRCA1 and BRCA2 genetic testing for all epithelial ovarian cancer patients irrespective of histology. Here, BRCA2 is linked to ovarian carcinoma.